Search research articles
Contact Us
Filters
Showing results (111-120 of 118) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 118 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
M C Piccirillo, G Scambia, A Bologna, et al.
ESMO Open
|
May 20, 2025
HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib
L Beltrame, L Mannarino, A Sergi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2024
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
S Pignata, D Califano, D Lorusso, et al.
ESMO Open
|
November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey
M Turinetto, C Marchetti, G Scandurra, et al.
ESMO Open
|
September 26, 2022
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial
E D Capoluongo, B Pellegrino, L Arenare, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancer
A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2024
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
J A Ledermann, X Matias-Guiu, F Amant, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 118) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 118 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
M C Piccirillo, G Scambia, A Bologna, et al.
ESMO Open
|
May 20, 2025
HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib
L Beltrame, L Mannarino, A Sergi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2024
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
S Pignata, D Califano, D Lorusso, et al.
ESMO Open
|
November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey
M Turinetto, C Marchetti, G Scandurra, et al.
ESMO Open
|
September 26, 2022
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial
E D Capoluongo, B Pellegrino, L Arenare, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancer
A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2024
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
J A Ledermann, X Matias-Guiu, F Amant, et al.
Page
of 12